The Global Vertical Farming For Medicinal Cannabis Market was valued at USD 331 million in 2025 and is estimated to grow at a CAGR of 16.9% to reach USD 1.57 billion by 2035.
Market growth is driven by the tightening of pharmaceutical cultivation standards, the increasing formalization of medical cannabis supply chains, and the global transition toward GMP and GACP-compliant production environments. Vertical farming systems are becoming a foundational infrastructure for licensed cannabis cultivation as regulatory frameworks evolve toward stricter quality assurance, traceability, and product consistency requirements. Countries across Europe are advancing structured legalization and regulatory pathways that are reshaping cultivation models into highly controlled, facility-based production systems. This transition is creating a dual-tier market structure in which compliant operators with certified vertical farming infrastructure gain access to high-value pharmaceutical distribution networks, while non-compliant producers face restricted market participation. As regulatory alignment continues to strengthen and production standards become more harmonized across regions, demand for advanced vertical farming systems designed for medicinal cannabis cultivation is expected to grow significantly over the forecast period.
Hydroponics accounted for 62% share in 2025, generating USD 205.2 million. Its leadership position is supported by its ability to deliver precise nutrient control, consistent crop quality, and compatibility with pharmaceutical-grade cultivation environments. Hydroponic systems provide a highly controlled growth medium that enables stable cannabinoid profiles and standardized production outputs, which are critical for medical cannabis applications. As vertical farming operations continue to scale, hydroponics is expected to remain the preferred cultivation method due to its operational reliability and established integration within regulated production frameworks.
The hardware segment held a 59.5% share, generating USD 196.9 million in 2025. It includes core cultivation infrastructure such as lighting systems, climate control equipment, nutrient delivery technologies, automated racking systems, monitoring devices, and water treatment solutions. These components are essential for maintaining pharmaceutical-grade cultivation environments and ensuring compliance with strict regulatory standards. Growing investment in facility automation and precision-controlled cultivation environments continues to support strong demand for advanced hardware systems across the industry.
North America Vertical Farming for Medicinal Cannabis Market accounted for 9% share in 2025. The region recorded the lowest growth rate among global markets due to regulatory restrictions limiting large-scale pharmaceutical cannabis cultivation in certain jurisdictions. However, structured regulatory frameworks in parts of the region continue to support controlled expansion of GMP-certified cultivation facilities. The presence of standardized compliance systems and increasing adoption of pharmaceutical-grade cultivation practices is gradually contributing to market development, particularly in regulated production environments.
Key companies operating in the Global Vertical Farming for Medicinal Cannabis Market include Curaleaf International, Agrify Corporation, Village Farms International, Urban Crop Solutions, Fluence (Signify), Heliospectra AB, AEssense Corporation, Pipp Horticulture, Little Green Pharma Ltd, Tilray Deutschland GmbH, Avextra Pharma GmbH, InterCure Ltd / Canndoc, Cann Group Limited, Bedrocan International, and Sanlight GmbH. Companies operating in the Vertical Farming for Medicinal Cannabis Market are focusing on regulatory compliance, technological innovation, and facility expansion to strengthen their competitive position. Investments in GMP-certified infrastructure, advanced cultivation systems, and precision-controlled environments enable firms to meet stringent pharmaceutical standards. Many companies are forming strategic partnerships with research organizations, healthcare stakeholders, and regulatory bodies to accelerate product validation and market access. Expansion into regions with established medical cannabis frameworks is supporting geographic diversification and revenue growth.
This product will be delivered within 2-4 business days.
Market growth is driven by the tightening of pharmaceutical cultivation standards, the increasing formalization of medical cannabis supply chains, and the global transition toward GMP and GACP-compliant production environments. Vertical farming systems are becoming a foundational infrastructure for licensed cannabis cultivation as regulatory frameworks evolve toward stricter quality assurance, traceability, and product consistency requirements. Countries across Europe are advancing structured legalization and regulatory pathways that are reshaping cultivation models into highly controlled, facility-based production systems. This transition is creating a dual-tier market structure in which compliant operators with certified vertical farming infrastructure gain access to high-value pharmaceutical distribution networks, while non-compliant producers face restricted market participation. As regulatory alignment continues to strengthen and production standards become more harmonized across regions, demand for advanced vertical farming systems designed for medicinal cannabis cultivation is expected to grow significantly over the forecast period.
Hydroponics accounted for 62% share in 2025, generating USD 205.2 million. Its leadership position is supported by its ability to deliver precise nutrient control, consistent crop quality, and compatibility with pharmaceutical-grade cultivation environments. Hydroponic systems provide a highly controlled growth medium that enables stable cannabinoid profiles and standardized production outputs, which are critical for medical cannabis applications. As vertical farming operations continue to scale, hydroponics is expected to remain the preferred cultivation method due to its operational reliability and established integration within regulated production frameworks.
The hardware segment held a 59.5% share, generating USD 196.9 million in 2025. It includes core cultivation infrastructure such as lighting systems, climate control equipment, nutrient delivery technologies, automated racking systems, monitoring devices, and water treatment solutions. These components are essential for maintaining pharmaceutical-grade cultivation environments and ensuring compliance with strict regulatory standards. Growing investment in facility automation and precision-controlled cultivation environments continues to support strong demand for advanced hardware systems across the industry.
North America Vertical Farming for Medicinal Cannabis Market accounted for 9% share in 2025. The region recorded the lowest growth rate among global markets due to regulatory restrictions limiting large-scale pharmaceutical cannabis cultivation in certain jurisdictions. However, structured regulatory frameworks in parts of the region continue to support controlled expansion of GMP-certified cultivation facilities. The presence of standardized compliance systems and increasing adoption of pharmaceutical-grade cultivation practices is gradually contributing to market development, particularly in regulated production environments.
Key companies operating in the Global Vertical Farming for Medicinal Cannabis Market include Curaleaf International, Agrify Corporation, Village Farms International, Urban Crop Solutions, Fluence (Signify), Heliospectra AB, AEssense Corporation, Pipp Horticulture, Little Green Pharma Ltd, Tilray Deutschland GmbH, Avextra Pharma GmbH, InterCure Ltd / Canndoc, Cann Group Limited, Bedrocan International, and Sanlight GmbH. Companies operating in the Vertical Farming for Medicinal Cannabis Market are focusing on regulatory compliance, technological innovation, and facility expansion to strengthen their competitive position. Investments in GMP-certified infrastructure, advanced cultivation systems, and precision-controlled environments enable firms to meet stringent pharmaceutical standards. Many companies are forming strategic partnerships with research organizations, healthcare stakeholders, and regulatory bodies to accelerate product validation and market access. Expansion into regions with established medical cannabis frameworks is supporting geographic diversification and revenue growth.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Growing Technology, 2022-2035 (USD Million)
Chapter 6 Market Estimates and Forecast, by Component, 2022-2035 (USD Million)
Chapter 7 Market Estimates and Forecast, by Facility Structure, 2022-2035 (USD Million)
Chapter 8 Market Estimates and Forecast, by End Use Type, 2022-2035 (USD Million)
Chapter 9 Market Estimates and Forecast, by Region, 2022-2035 (USD Million)
Chapter 10 Company Profiles
Companies Mentioned
- Agrify Corporation
- Village Farms International, Inc.
- Urban Crop Solutions
- Fluence (Signify)
- Heliospectra AB
- AEssense Corporation
- Pipp Horticulture
- Little Green Pharma Ltd
- Tilray Deutschland GmbH
- Avextra Pharma GmbH
- InterCure Ltd / Canndoc
- Cann Group Limited
- Bedrocan International
- Sanlight GmbH
- Curaleaf International
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 210 |
| Published | June 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 331 Million |
| Forecasted Market Value ( USD | $ 1570 Million |
| Compound Annual Growth Rate | 16.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
